GO:0001861 complement component C4b receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001861 defines the molecular function of binding the C4b fragment of complement component C4 and transmitting a signal across the membrane to initiate a cellular response.
• The classical complement cascade generates C4b, which covalently attaches to target surfaces and serves as a ligand for C4b receptors such as CR1 (CD35).
• CR1 (C3b/C4b receptor) is the prototypical C4b receptor; its N-terminal short consensus repeats, especially SCR 3, are critical for inhibiting classical and alternative complement pathways.
• C4b receptor activity is central to immune complex clearance, regulation of complement activation, and protection of host cells from complement-mediated damage.
• Dysregulated complement, including C4b receptor function, is implicated in cardiovascular disease, synucleinopathies, and age-associated inflammatory conditions.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of C4b receptor structure-function relationships and disease relevance.
Description
Complement component C4b receptor activity (GO:0001861) is a molecular function defined as the binding of the C4b fragment of complement component C4 and the transmission of a signal across the membrane to initiate a change in cell activity. This activity is a key checkpoint in the classical complement cascade, where C4b covalently attaches to immune complexes and pathogen surfaces, and its recognition by specific receptors modulates downstream inflammatory and clearance responses. Researchers study this term to understand how complement activation is controlled at the receptor level and how dysregulation contributes to human disease. The best-characterized C4b receptor is complement receptor 1 (CR1, CD35), a large membrane glycoprotein that binds C3b and C4b and acts as a cofactor for factor I-mediated cleavage, thereby dampening complement amplification. Structural and functional studies have mapped the C4b-binding determinants to the N-terminal short consensus repeat (SCR) domains of CR1, with SCR 3 playing a non-redundant role in inhibiting both classical and alternative pathways. Because C4b receptor activity sits at the interface of innate immunity and inflammation, it is a compelling target for research in cardiovascular disease, neurodegeneration, and infection.
complement component C4b receptor activity At A Glance
| GO ID | GO:0001861 |
|---|---|
| GO term | complement component C4b receptor activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Combining with the C4b product of the classical complement cascade and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| Major function | Binding C4b and transducing a signal to regulate complement activation and cellular responses. |
| Prototypical receptor | CR1 (CD35, C3b/C4b receptor) |
| Key structural domain | Short consensus repeats (SCRs), especially SCR 3 of CR1 |
| Related processes | Classical complement pathway, immune complex clearance, complement regulation |
What Is GO:0001861?
In plain terms, GO:0001861 describes the job of a cell-surface receptor that grabs C4b, a piece of the complement protein C4, and then sends a signal into the cell to change what the cell does. This is not just binding; it is a receptor activity that couples C4b recognition to an intracellular response, as defined by QuickGO.
Why Is complement component C4b receptor activity Important in Cell Biology?
C4b receptor activity is important because it controls the amplification and resolution of the classical complement cascade, a central arm of innate immunity and inflammation. By binding C4b, receptors such as CR1 not only mediate cellular responses but also serve as cofactors for the degradation of C4b, preventing excessive complement activation that can damage host tissues. This regulatory function links C4b receptor activity to diseases including cardiovascular disorders, synucleinopathies, and age-related inflammatory conditions, making it a relevant target for both mechanistic studies and therapeutic development.
• Regulates the classical complement pathway by binding C4b and promoting its inactivation.
• Protects host cells from complement-mediated lysis and inflammation.
• Facilitates clearance of immune complexes and apoptotic cells.
• Modulates cardiovascular disease progression through complement activity.
• Implicated in synucleinopathy-associated complement dysregulation.
• Shows age-associated changes in complement proteins during infection.
• C4b-binding protein levels vary with age and inflammation, affecting C4b availability.
• Provides a target for pharmacological inhibition of complement in disease.
• CR1 SCR domains are critical for inhibiting both classical and alternative pathways.
• Relevant to cancer-related complement changes in irradiated models.
What Happens During complement component C4b receptor activity?
C4b generation and deposition
In simple terms: First, the complement system cuts C4 into C4b, which sticks to the surface of targets like bacteria or immune complexes.
In the classical complement cascade, activation of C1 leads to cleavage of C4 into C4a and C4b. C4b contains a reactive thioester that covalently attaches to nearby surfaces, tagging them for immune recognition. This deposition is a prerequisite for C4b receptor engagement.
Receptor binding of C4b
In simple terms: Next, a receptor on the cell membrane grabs the deposited C4b.
C4b receptors, such as CR1 (CD35), bind C4b through their extracellular short consensus repeat (SCR) domains. Structural studies have shown that SCR 3 of CR1 is particularly important for this interaction and for subsequent complement inhibition.
Signal transmission across the membrane
In simple terms: Once the receptor binds C4b, it sends a signal into the cell that changes the cell's behavior.
According to the GO definition, C4b receptor activity involves transmitting a signal from one side of the membrane to the other to initiate a change in cell activity. This can include cytoskeletal rearrangements, phagocytosis, or modulation of inflammatory cytokine release, depending on the cell type.
Cofactor activity and C4b degradation
In simple terms: The receptor also helps break down C4b, putting a brake on the complement cascade.
CR1 acts as a cofactor for factor I-mediated cleavage of C4b, generating C4c and C4d fragments. This regulatory function prevents excessive complement activation and protects host tissues.
Downstream cellular responses
In simple terms: Finally, the cell responds by clearing targets or adjusting its immune activity.
C4b receptor engagement can promote immune adherence, phagocytosis of C4b-opsonized targets, and clearance of immune complexes. These responses are part of the innate immune defense and help resolve inflammation.
Key Genes Involved in GO:0001861 complement component C4b receptor activity
The following genes and proteins are directly or functionally associated with complement component C4b receptor activity and its regulatory network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CR1 | C3b/C4b receptor (CD35); binds C4b and acts as cofactor for factor I | Prototypical C4b receptor; SCR 3 critical for complement inhibition |
| C4A | Encodes complement C4A; source of C4b fragment | C4b generation and deposition on targets |
| C4B | Encodes complement C4B; source of C4b fragment | C4b generation and deposition on targets |
| C4BPA | C4b-binding protein alpha chain; regulates C4b | Modulates C4b availability and complement activity |
| C4BPB | C4b-binding protein beta chain; regulates C4b | Modulates C4b availability and complement activity |
| C1QA | Subunit of C1q; initiates classical pathway | Upstream of C4b generation |
| C1QB | Subunit of C1q; initiates classical pathway | Upstream of C4b generation |
| C1QC | Subunit of C1q; initiates classical pathway | Upstream of C4b generation |
| C1R | C1r serine protease; activates C1s | Cleaves C4 to generate C4b |
| C1S | C1s serine protease; cleaves C4 | Directly produces C4b |
| C2 | Forms C3 convertase with C4b | Downstream of C4b deposition |
| C3 | Central complement component; opsonin | Amplification loop and immune clearance |
| CFI | Factor I; cleaves C4b in presence of cofactors | Degrades C4b, regulated by CR1 |
| CR2 | C3d receptor; part of B-cell co-receptor | Related complement receptor; not C4b-specific |
| CD46 | Membrane cofactor protein; binds C3b/C4b | Regulates complement on host cells |
| CD55 | Decay-accelerating factor; inhibits C3 convertase | Protects cells from complement |
| PTX3 | Pentraxin; interacts with complement components | Modulates complement activation and regulation |
| SAP | Serum amyloid P; binds C4b-binding protein | Influences complement regulation |
How Is complement component C4b receptor activity Regulated?
C4b receptor activity is regulated at multiple levels. The availability of C4b is controlled by C4b-binding protein (C4BP), whose serum levels vary with age and inflammation. CR1 itself is regulated by shedding and by its interaction with factor I, which cleaves C4b. Pentraxins such as PTX3 and SAP can modulate complement activation and regulation, indirectly affecting C4b receptor engagement. In disease states, complement dysregulation can alter the balance of C4b generation and degradation, impacting receptor activity.
complement component C4b receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CR1 | Complement dysregulation, cardiovascular disease | CR1 knockout and point-mutation cell lines |
| C4A/C4B | Autoimmunity, infection susceptibility | C4A/C4B knockout models |
| C4BPA | Inflammation, age-related complement changes | C4BPA overexpression and knockout |
| CFI | Atypical hemolytic uremic syndrome | CFI point-mutation knock-in |
| CD46 | Atypical hemolytic uremic syndrome | CD46 knockout and knock-in |
Cardiovascular disease
Complement activity, including C4b-mediated pathways, contributes to cardiovascular pathology. Pharmacological inhibition of complement is being explored as a therapeutic strategy in cardiovascular disease, highlighting the importance of C4b receptor function in disease progression.
Synucleinopathies and neurodegeneration
Complement dysregulation occurs during the early phases of synucleinopathy, suggesting that C4b receptor activity may influence neuroinflammation and disease progression. Understanding these mechanisms could reveal new targets for intervention.
Age-associated and inflammatory conditions
Age-associated molecular mechanisms in SARS-CoV-2 infection involve complement system changes, and C4b-binding protein levels are influenced by age and inflammation. These findings link C4b receptor activity to immune aging and infection responses.
Cancer and radiation response
Plasma proteomic analysis in irradiated mice during mammary carcinogenesis revealed complement system changes, indicating that C4b receptor activity may be relevant to cancer-related inflammation and radiation responses.
From complement component C4b receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CR1 SCR 3 mediate C4b binding and complement inhibition? | CR1 point-mutation (SCR 3 deletion) knock-in cell line |
| What is the effect of CR1 loss on complement activation? | CR1 knockout cell line |
| Can C4b receptor activity be enhanced by overexpression? | CR1 overexpression cell line |
| How does C4b-binding protein regulate C4b availability? | C4BPA knockout and overexpression models |
| What is the role of C4b receptor in synucleinopathy? | CR1 knockout in neuronal cell models |
| Does age affect complement receptor expression? | Aged vs young cell models |
How to Study the complement component C4b receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for C4b receptor activity | Discovery of novel complement regulators |
| Surface plasmon resonance | Binding affinity of C4b to CR1 | Structure-function analysis of SCR domains |
| Flow cytometry | C4b deposition and receptor expression | Immune complex clearance studies |
| ELISA | Serum levels of C4b-binding protein | Age and inflammation studies |
| Proteomics | Complement protein abundance | Disease biomarker discovery |
| Multi-omics integration | Age-associated molecular mechanisms | SARS-CoV-2 infection studies |
| Immunohistochemistry | Tissue localization of complement components | Synucleinopathy research |
| Western blot | Protein expression of CR1 and cofactors | Knockout validation |
CRISPR knockout screening
Genome-wide CRISPR knockout screens can identify genes required for C4b receptor activity and complement-mediated cellular responses. This approach is useful for discovering novel regulators of the classical complement pathway.
Surface plasmon resonance (SPR) and binding assays
SPR and ELISA-based binding assays measure the affinity and kinetics of C4b binding to CR1 and other receptors. These methods are essential for structure-function studies of SCR domains.
Flow cytometry and immunoassays
Flow cytometry can detect C4b deposition on cell surfaces and receptor expression levels. Immunoassays quantify complement components in serum and cell culture supernatants.
Proteomics and multi-omics
Plasma proteomics and integrative multi-omics analyses reveal complement system changes in disease models and human samples, providing insights into C4b receptor regulation.
How CRISPR Can Be Used to Study GO:0001861 complement component C4b receptor activity
Knockout
CRISPR knockout of CR1 or other C4b receptor genes can abolish C4b binding and complement regulatory function, allowing researchers to assess the contribution of this activity to immune complex clearance and inflammation.
Point Mutation
Point mutations in CR1 SCR domains, especially SCR 3, can dissect the specific residues required for C4b binding and signal transmission, providing mechanistic insights into receptor function.
Knock-in
Knock-in of disease-associated variants or tagged receptors enables real-time tracking of C4b receptor localization and dynamics in live cells, linking genotype to phenotype.
Overexpression
Overexpression of CR1 or other C4b receptors can enhance complement regulation and protect cells from complement-mediated damage, serving as a gain-of-function model for therapeutic studies.
How EDITGENE Supports complement component C4b receptor activity Research
Researchers studying complement component C4b receptor activity-related genes often need to determine whether a candidate gene is causally involved in C4b binding, signal transduction, or complement regulation. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for complement component C4b receptor activity research.
Frequently Asked Questions About complement component C4b receptor activity
What is complement component C4b receptor activity?
It is a molecular function (GO:0001861) where a receptor binds the C4b fragment of complement C4 and transmits a signal across the membrane to change cell activity.
What genes are involved in complement component C4b receptor activity?
Key genes include CR1 (CD35), C4A, C4B, C4BPA, C4BPB, and complement regulators such as CFI and CD46.
Which receptor is the prototypical C4b receptor?
CR1 (CD35, C3b/C4b receptor) is the best-characterized C4b receptor, with SCR 3 critical for function.
How is C4b receptor activity regulated?
It is regulated by C4b-binding protein, factor I, and receptor shedding, with levels influenced by age and inflammation.
What diseases are associated with C4b receptor dysfunction?
Cardiovascular disease, synucleinopathies, age-associated inflammation, and cancer-related complement changes.
How can I study C4b receptor activity in the lab?
CRISPR knockout, point mutation, knock-in, overexpression, SPR, flow cytometry, and proteomics are common approaches.
What is the role of CR1 SCR 3 in complement regulation?
SCR 3 of CR1 plays a critical role in inhibiting both classical and alternative complement pathways.
Does age affect C4b-binding protein levels?
Yes, serum levels of C4b-binding protein are influenced by age and inflammation.
Is C4b receptor activity involved in neurodegeneration?
Complement dysregulation occurs in early synucleinopathy, suggesting a role for C4b receptor activity in neuroinflammation.
What CRISPR models are available for C4b receptor research?
EDITGENE offers knockout, point mutation, knock-in, overexpression cell models, and CRISPR library screening for complement genes.
Conclusion
Complement component C4b receptor activity (GO:0001861) is a critical molecular function that links C4b deposition to cellular responses and complement regulation. The prototypical receptor CR1, through its SCR domains, exemplifies how C4b binding controls classical and alternative pathways. Dysregulation of this activity is implicated in cardiovascular disease, synucleinopathies, and age-associated inflammation, making it a valuable target for research. CRISPR-based models and multi-omics approaches provide powerful tools to dissect the mechanisms and disease relevance of C4b receptor activity, paving the way for new therapeutic strategies.
References
- 1. Ma YJ et al.. 2018. Pentraxins in Complement Activation and Regulation.. Front Immunol 9:3046 PMID: 30619374
- 2. Théroux P et al.. 2006. Complement activity and pharmacological inhibition in cardiovascular disease.. Can J Cardiol 22 Suppl B(Suppl B):18B-24B PMID: 16498508
- 3. Khan H et al.. 2026. Complement dysregulation during the early phases of synucleinopathy.. Acta Neuropathol 152(1) PMID: 42477211
- 4. Marcovina SM et al.. 1991. Determination of serum levels of complement component C4b-binding protein: influence of age and inflammation.. Int J Clin Lab Res 21(2):171-5 PMID: 1815762
- 5. Tang X et al.. 2025. Integrative Multi-Omics Analysis Reveals Age-Associated Molecular Mechanisms in SARS-CoV-2 Infection.. J Med Virol 97(12):e70730 PMID: 41378745
- 6. Mossakowska D et al.. 1999. Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation.. Eur J Immunol 29(6):1955-65 PMID: 10382758
- 7. Akbarzadeh T et al.. 2025. Plasma Proteomic Analysis Reveals Complement System Changes in Irradiated Female BALB/c Mice during Mammary Carcinogenesis.. Cancer Res Commun 5(8):1409-1418 PMID: 40757647
- 8. Khan H et al.. 2026. Complement Dysregulation During the Early Phases of Synucleinopathy.. bioRxiv PMID: 42094452
